Recent PSNL News
- Personalis to Announce First Quarter 2024 Financial Results • Business Wire • 04/24/2024 08:01:00 PM
- Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 03/28/2024 08:01:00 PM
- Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • Business Wire • 03/28/2024 01:00:00 PM
- Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring • Business Wire • 03/26/2024 01:00:00 PM
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/19/2024 08:43:00 PM
- Personalis Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/28/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:00:11 PM
- Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/14/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:30:33 PM
- Personalis to Participate at Upcoming Investor Conferences • Business Wire • 01/31/2024 09:01:00 PM
- Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology • Business Wire • 01/30/2024 02:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/29/2024 09:00:59 PM
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/17/2024 09:15:00 PM
- Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay • Business Wire • 01/16/2024 02:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/10/2024 05:15:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 02:09:39 PM
- Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance • Business Wire • 01/05/2024 02:05:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/21/2023 10:15:27 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/21/2023 10:12:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 11:09:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 11:02:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/05/2023 09:05:58 PM
- Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives • Business Wire • 12/04/2023 02:15:00 PM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM